Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status

PURPOSE: To evaluate the effects of phosphodiesterase type 5 inhibitor (PDE5i) on urinary continence recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). MATERIALS AND METHODS: Between 2002 and 2012, 137 of 154 consecutive patients who underwent BNSRP in our institution retrospectiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Investig Clin Urol
Main Authors: Kaiho, Yasuhiro, Yamashita, Shinichi, Ito, Akihiro, Kawasaki, Yoshihide, Izumi, Hideaki, Kawamorita, Naoki, Adachi, Hisanobu, Mitsuzuka, Koji, Arai, Yoichi
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Urological Association 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5017554/
https://ncbi.nlm.nih.gov/pubmed/27617318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2016.57.5.357
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados